421 related articles for article (PubMed ID: 18404135)
1. Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi-center assessment.
Geier DA; Mumper E; Gladfelter B; Coleman L; Geier MR
Neuro Endocrinol Lett; 2008 Apr; 29(2):272-80. PubMed ID: 18404135
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of thimerosal-containing Rho(D)-immune globulin administration as a risk factor for autistic disorders.
Geier DA; Geier MR
J Matern Fetal Neonatal Med; 2007 May; 20(5):385-90. PubMed ID: 17674242
[TBL] [Abstract][Full Text] [Related]
3. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
Geier D; Geier MR
Int J Toxicol; 2004; 23(6):369-76. PubMed ID: 15764492
[TBL] [Abstract][Full Text] [Related]
4. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.
Young HA; Geier DA; Geier MR
J Neurol Sci; 2008 Aug; 271(1-2):110-8. PubMed ID: 18482737
[TBL] [Abstract][Full Text] [Related]
5. Maternal Rh D status, anti-D immune globulin exposure during pregnancy, and risk of autism spectrum disorders.
Croen LA; Matevia M; Yoshida CK; Grether JK
Am J Obstet Gynecol; 2008 Sep; 199(3):234.e1-6. PubMed ID: 18554566
[TBL] [Abstract][Full Text] [Related]
6. Discussion: Prenatal exposure to anti-D immune globulin and autism risk by Croen et al.
DeFranco E; Gross G; Shanks A; Johnson T; Shen T
Am J Obstet Gynecol; 2008 Sep; 199(3):e1-4. PubMed ID: 18771966
[No Abstract] [Full Text] [Related]
7. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
Andrews N; Miller E; Grant A; Stowe J; Osborne V; Taylor B
Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
[TBL] [Abstract][Full Text] [Related]
8. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
Thompson WW; Price C; Goodson B; Shay DK; Benson P; Hinrichsen VL; Lewis E; Eriksen E; Ray P; Marcy SM; Dunn J; Jackson LA; Lieu TA; Black S; Stewart G; Weintraub ES; Davis RL; DeStefano F;
N Engl J Med; 2007 Sep; 357(13):1281-92. PubMed ID: 17898097
[TBL] [Abstract][Full Text] [Related]
9. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis.
Geier DA; Geier MR
Med Sci Monit; 2005 Apr; 11(4):CR160-70. PubMed ID: 15795695
[TBL] [Abstract][Full Text] [Related]
10. An assessment of downward trends in neurodevelopmental disorders in the United States following removal of Thimerosal from childhood vaccines.
Geier DA; Geier MR
Med Sci Monit; 2006 Jun; 12(6):CR231-9. PubMed ID: 16733480
[TBL] [Abstract][Full Text] [Related]
11. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
Heron J; Golding J;
Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
[TBL] [Abstract][Full Text] [Related]
12. Prenatal exposure to anti-D immune globulin and autism risk: Croen et al.
DeFranco E; Gross G; Shanks A; Johnson T; Shen T
Am J Obstet Gynecol; 2008 Sep; 199(3):322-3. PubMed ID: 18772000
[No Abstract] [Full Text] [Related]
13. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
Price CS; Thompson WW; Goodson B; Weintraub ES; Croen LA; Hinrichsen VL; Marcy M; Robertson A; Eriksen E; Lewis E; Bernal P; Shay D; Davis RL; DeStefano F
Pediatrics; 2010 Oct; 126(4):656-64. PubMed ID: 20837594
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between Rh status, Rh immune globulin in pregnancy and autism.
Miles JH; Takahashi TN
Am J Med Genet A; 2007 Jul; 143A(13):1397-407. PubMed ID: 17508426
[TBL] [Abstract][Full Text] [Related]
15. Prenatal and perinatal morbidity in children with Tourette syndrome and attention-deficit hyperactivity disorder.
Pringsheim T; Sandor P; Lang A; Shah P; O'Connor P
J Dev Behav Pediatr; 2009 Apr; 30(2):115-21. PubMed ID: 19322105
[TBL] [Abstract][Full Text] [Related]
16. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders.
Geier DA; Geier MR
Pediatr Rehabil; 2003; 6(2):97-102. PubMed ID: 14534046
[TBL] [Abstract][Full Text] [Related]
17. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases.
Verstraeten T; Davis RL; DeStefano F; Lieu TA; Rhodes PH; Black SB; Shinefield H; Chen RT;
Pediatrics; 2003 Nov; 112(5):1039-48. PubMed ID: 14595043
[TBL] [Abstract][Full Text] [Related]
18. The marriage-related risk factors during maternal pregnancy in children with attention-deficit hyperactivity disorder.
Lee CY; Chang YY; Lung FW
Child Care Health Dev; 2006 Mar; 32(2):205-11. PubMed ID: 16441855
[TBL] [Abstract][Full Text] [Related]
19. Regression of language and non-language skills in pervasive developmental disorders.
Meilleur AA; Fombonne E
J Intellect Disabil Res; 2009 Feb; 53(2):115-24. PubMed ID: 19054269
[TBL] [Abstract][Full Text] [Related]
20. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study.
Andersen SL; Laurberg P; Wu CS; Olsen J
BJOG; 2014 Oct; 121(11):1365-74. PubMed ID: 24605987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
